Abstract:Abstract Background: Defining effective early status of Alzheimer’s disease (AD) could be challenging, due to complexity in linking early and late stages in the progression and the internal biological heterogeneity within same status. We explore whether it is possible to verify and refine candidature early statuses in the AD progressions by comparing the neurological features learned by deep learning models. Methods: We collect functional magnetic resonance imaging (fMRI) data from 432 subjects, including 79 healthy controls (HCs), 109 amnestic mild cognitive impairments (aMCIs), 39 non-amnestic MCIs (naMCIs), 98 subjective cognitive declines (SCDs) and 107 ADs. We train graph convolutional networks (GCNs) based on multiscale functional networks to accurately classify aMCI from naMCI and HC from MCIs. The trained models are applied to AD and SCD groups to suggest the neural feature similarity (as the ratio of predictions) among the statuses and identify clinically informative subpopulations. The corresponding demographics, cognitive assessments, T1, and PET images are used to provide supportive evidences for sub-divided populations based on the model decisions. Results: The GCN model achieves 89.2±1.9% and 83.7±3.1% accuracies in aMCI-vs-naMCI and HC-vs-MCI classifications. The aMCI-vs-naMCI classification model identifies 71.8% of the AD subjects as aMCI. The HC-vs-MCI classification model suggests that 73.5% of the SCDs are MCI, in which 88.8% are further diagnosed as “aMCI” by the aMCI-vs-naMCI classifier. The analyses based on T1 and PET images suggests that the aMCI-like AD exhibits more globally elaborated Aβ depositions, severer glucose metabolism reduction and grey matter atrophy than naMCI-like AD after contrasted with clinical HCs. MCI-like SCD shows more reduction of glucose metabolism than HC-like SCD, baselined by clinical HCs. Further, aMCI-like SCD exhibits slightly elaborated Aβ while naMCI-like SCD shows none when compared to clinical HCs. MCI-like SCD has lower executive ability than HC-like SCD. aMCI-like SCD shows lower memory ability than naMCI-like SCD. Conclusions: This study suggests an overall neurological similarity among SCD, aMCI and AD from perspective of brain dynamics, and verifies the position of SCD and aMCI in the AD progression. Further, it offers a potentially refined progression progress, consisting of aMCI-like SCD, aMCI, and aMCI-like AD dementia. Clinical Trials Registration : The data collection has been registered as “ChiCTR2000036842”.

Role of hippocampal subfields in neurodegenerative disease progression analyzed with a multi-scale attention-based network

Altered Functional Connectivity Pattern of Hippocampal Subfields in Individuals with Objectively-Defined Subtle Cognitive Decline and Its Association with Cognition and Cerebrospinal Fluid Biomarkers

Multigroup Recognition of Dementia Patients with Dynamic Brain Connectivity under Multimodal Cortex Parcellation

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study

Neuropsychiatric symptoms associated multimodal brain networks in Alzheimer's disease

Polygenic Hazard Score Associated Multimodal Brain Networks along the Alzheimer's Disease Continuum.

Progressive Volume Atrophy in Hippocampal Subfields and the Correlation with Cognition in Alzheimer’s Disease and Mild Cognitive Impairment

A Multi-scale Attention-based Convolutional Network for Identification of Alzheimer's Disease Based on Hippocampal Subfields

Can Multi-Modal Neuroimaging Evidence from Hippocampus Provide Biomarkers for the Progression of Amnestic Mild Cognitive Impairment?

Machine Learning Decomposition of the Anatomy of Neuropsychological Deficit in Alzheimer's Disease and Mild Cognitive Impairment.

The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease

Progression of hippocampal subfield atrophy and asymmetry in Alzheimer's disease

Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer’s disease

Disrupted Functional Connectivity Between Perirhinal and Parahippocampal Cortices with Hippocampal Subfields in Patients with Mild Cognitive Impairment and Alzheimer's Disease.

Novel Iterative Attention Focusing Strategy for Joint Pathology Localization and Prediction of MCI Progression.

Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers

Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI.

Trajectories of the Hippocampal Subfields Atrophy in the Alzheimer's Disease: A Structural Imaging Study.

Classification of Alzheimer’s Disease Based on Abnormal Hippocampal Functional Connectivity and Machine Learning

Analysis of Hippocampus Evolution Patterns and Prediction of Conversion in Mild Cognitive Impairment Using Multivariate Morphometry Statistics.

Verifying and Refining Early Statuses in Alzheimer’s Disease Progression: A Possibility from Deep Feature Comparison